157 related articles for article (PubMed ID: 26276037)
1. TCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma.
Ho DW; Kai AK; Ng IO
Front Med; 2015 Sep; 9(3):322-30. PubMed ID: 26276037
[TBL] [Abstract][Full Text] [Related]
2. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
[TBL] [Abstract][Full Text] [Related]
3. Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma.
Li B; Xu T; Liu C; Meng G; Sun Y; Qian L; Wang S; Wei J; Yu D; Ding Y
Sci Rep; 2018 Jul; 8(1):11197. PubMed ID: 30046116
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
[TBL] [Abstract][Full Text] [Related]
6. Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
Zhao Y; Zhang L; Zhang Y; Meng B; Ying W; Qian X
Sci China Life Sci; 2019 Nov; 62(11):1481-1491. PubMed ID: 31313086
[TBL] [Abstract][Full Text] [Related]
7. Systemic transcriptome analysis of hepatocellular carcinoma.
Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
[TBL] [Abstract][Full Text] [Related]
8. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.
Wong CM; Wong CC; Lee JM; Fan DN; Au SL; Ng IO
Hepatology; 2012 May; 55(5):1453-61. PubMed ID: 22135159
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the selenotranscriptome expression in two hepatocellular carcinoma cell lines.
Guariniello S; Di Bernardo G; Colonna G; Cammarota M; Castello G; Costantini S
Anal Cell Pathol (Amst); 2015; 2015():419561. PubMed ID: 26199857
[TBL] [Abstract][Full Text] [Related]
10. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
11. Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium.
Cartularo L; Laulicht F; Sun H; Kluz T; Freedman JH; Costa M
Toxicol Appl Pharmacol; 2015 Nov; 288(3):399-408. PubMed ID: 26314618
[TBL] [Abstract][Full Text] [Related]
12. Identification of personalized dysregulated pathways in hepatocellular carcinoma.
Li H; Jiang X; Zhu S; Sui L
Pathol Res Pract; 2017 Apr; 213(4):327-332. PubMed ID: 28215647
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
Wojcicka A; Swierniak M; Kornasiewicz O; Gierlikowski W; Maciag M; Kolanowska M; Kotlarek M; Gornicka B; Koperski L; Niewinski G; Krawczyk M; Jazdzewski K
Int J Biochem Cell Biol; 2014 Aug; 53():208-17. PubMed ID: 24875649
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.
Simon EP; Freije CA; Farber BA; Lalazar G; Darcy DG; Honeyman JN; Chiaroni-Clarke R; Dill BD; Molina H; Bhanot UK; La Quaglia MP; Rosenberg BR; Simon SM
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):E5916-25. PubMed ID: 26489647
[TBL] [Abstract][Full Text] [Related]
15. Gene expression signature of human HepG2 cell line.
Costantini S; Di Bernardo G; Cammarota M; Castello G; Colonna G
Gene; 2013 Apr; 518(2):335-45. PubMed ID: 23357223
[TBL] [Abstract][Full Text] [Related]
16. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.
Law PT; Qin H; Ching AK; Lai KP; Co NN; He M; Lung RW; Chan AW; Chan TF; Wong N
J Hepatol; 2013 Jun; 58(6):1165-73. PubMed ID: 23376363
[TBL] [Abstract][Full Text] [Related]
17. Distinct molecular etiologies of male and female hepatocellular carcinoma.
Natri HM; Wilson MA; Buetow KH
BMC Cancer; 2019 Oct; 19(1):951. PubMed ID: 31615477
[TBL] [Abstract][Full Text] [Related]
18. The HOX gene network in hepatocellular carcinoma.
Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
[TBL] [Abstract][Full Text] [Related]
19. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
Ramesh V; Ganesan K
Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
[TBL] [Abstract][Full Text] [Related]
20. New biomarkers and therapeutic targets of human liver cancer: Transcriptomic findings.
Qin L; Huang D; Huang J; Huang H
Biofactors; 2021 Nov; 47(6):1016-1031. PubMed ID: 34379335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
